INIS
patients
100%
coronaries
67%
therapy
43%
interventions
37%
risks
34%
valves
34%
myocardial infarction
27%
elevation
25%
design
15%
ischemia
13%
reviews
13%
aspirin
12%
genetics
12%
comparative evaluations
12%
thrombosis
11%
genotype
10%
arteries
10%
diseases
9%
drugs
8%
mortality
8%
safety
8%
surgery
8%
doses
7%
hazards
6%
anticoagulants
6%
guidelines
6%
inhibition
6%
reactivity
6%
cost
5%
hospitals
5%
Keyphrases
Transcatheter Aortic Valve Implantation
26%
Acute Coronary Syndrome
25%
Percutaneous Coronary Intervention
23%
Bleeding
21%
Popular
20%
ST-elevation Myocardial Infarction (STEMI)
20%
Dual Antiplatelet Therapy
19%
Clopidogrel
17%
Ticagrelor
16%
P2Y12 Inhibitors
16%
Antithrombotic Therapy
14%
Aspirin
13%
Bleeding Risk
10%
Myocardial Infarction
9%
CYP2C19 Polymorphism
8%
Non-ST-segment Elevation Acute Coronary Syndrome (NSTE-ACS)
8%
Zalunfiban
8%
Prasugrel
7%
Major Bleeding
7%
Antiplatelet Therapy
6%
Confidence Interval
6%
Elderly Patients
6%
Primary Percutaneous Coronary Intervention
6%
Ischemic Events
6%
Oral Anticoagulation
6%
Atrial Fibrillation
5%
Bleeding Events
5%
Glycoprotein IIb/IIIa Inhibitors
5%
Genotype-guided
5%
Clinical Outcomes
5%
Medicine and Dentistry
Percutaneous Aortic Valve Replacement
30%
Bleeding
23%
Percutaneous Coronary Intervention
21%
Acute Coronary Syndrome
20%
Antiplatelet
19%
Antithrombotic
16%
Antithrombotic Therapy
14%
ST Segment Elevation Myocardial Infarction
9%
Ticagrelor
8%
Thrombosis
8%
Acetylsalicylic Acid
8%
Meta-Analysis
7%
Apoplexy
7%
Coronary Artery Disease
6%
Cardiovascular System
6%
Anticoagulation
6%
Systematic Review
6%
Randomized Controlled Trial
6%
Major Bleeding
6%
Myocardial Infarction
6%
Clopidogrel
5%
Atrial Fibrillation
5%
Platelet Reactivity
5%
Prasugrel
5%
Quality of Life
5%